{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:38:51Z","timestamp":1793162331057,"version":"4.5.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17927-w","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:05:23Z","timestamp":1760519123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity"],"prefix":"10.1038","volume":"15","author":[{"given":"Fatima","family":"Quddos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"de Lima Bovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacarya","family":"Elbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Tegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin M.","family":"Gatchalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Kablinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra G.","family":"DiFeliceantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren K.","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"17927_CR1","unstructured":"NIAAA. Alcohol Use in the United States: Age Groups and Demographic Characteristics. (2025). https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohol-topics-z\/alcohol-facts-and-statistics\/alcohol-use-united-states-age-groups-and-demographic-characteristics."},{"key":"17927_CR2","unstructured":"CDC. Alcohol Use and Your Health. Alcohol Use (2025). https:\/\/www.cdc.gov\/alcohol\/about-alcohol-use\/index.html."},{"key":"17927_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","volume":"10","author":"B Secretan","year":"2009","unstructured":"Secretan, B. et al. A review of human carcinogens\u2013Part E: tobacco, Areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 10, 1033\u20131034 (2009).","journal-title":"Lancet Oncol."},{"key":"17927_CR4","unstructured":"Assistant Secretary for Health (ASH). Alcohol and Cancer Risk. HHS.gov (2024). https:\/\/www.hhs.gov\/surgeongeneral\/reports-and-publications\/alcohol-cancer\/index.html"},{"key":"17927_CR5","doi-asserted-by":"publisher","first-page":"e2022942","DOI":"10.1001\/jamanetworkopen.2020.22942","volume":"3","author":"MS Pollard","year":"2020","unstructured":"Pollard, M. S., Tucker, J. S. & Green, H. D. Jr. Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US. JAMA Netw. Open. 3, e2022942 (2020).","journal-title":"JAMA Netw. Open."},{"key":"17927_CR6","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1001\/jama.2022.4308","volume":"327","author":"AM White","year":"2022","unstructured":"White, A. M., Castle, I. J. P., Powell, P. A., Hingson, R. W. & Koob, G. F. Alcohol-related deaths during the COVID-19 pandemic. JAMA 327, 1704\u20131706 (2022).","journal-title":"JAMA"},{"key":"17927_CR7","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1038\/tp.2015.68","volume":"5","author":"P Suchankova","year":"2015","unstructured":"Suchankova, P. et al. The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence. Transl Psychiatry. 5, e583\u2013e583 (2015).","journal-title":"Transl Psychiatry"},{"key":"17927_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41398-020-00923-1","volume":"10","author":"D Vall\u00f6f","year":"2020","unstructured":"Vall\u00f6f, D., Kalafateli, A. L. & Jerlhag, E. Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats. Transl Psychiatry. 10, 238 (2020).","journal-title":"Transl Psychiatry"},{"key":"17927_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/adb.12295","volume":"21","author":"D Vall\u00f6f","year":"2016","unstructured":"Vall\u00f6f, D. et al. The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents. Addict. Biol. 21, 422\u2013437 (2016).","journal-title":"Addict. Biol."},{"key":"17927_CR10","doi-asserted-by":"publisher","first-page":"599646","DOI":"10.3389\/fnins.2020.599646","volume":"14","author":"VN Marty","year":"2020","unstructured":"Marty, V. N. et al. Long-acting glucagon-like peptide-1 receptor agonists suppress voluntary alcohol intake in male Wistar rats. Front. Neurosci. 14, 599646 (2020).","journal-title":"Front. Neurosci."},{"key":"17927_CR11","doi-asserted-by":"publisher","first-page":"104642","DOI":"10.1016\/j.ebiom.2023.104642","volume":"93","author":"C Aran\u00e4s","year":"2023","unstructured":"Aran\u00e4s, C. et al. Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats. EBioMedicine 93, 104642 (2023).","journal-title":"EBioMedicine"},{"key":"17927_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.psyneuen.2019.02.006","volume":"103","author":"D Vall\u00f6f","year":"2019","unstructured":"Vall\u00f6f, D., Kalafateli, A. L. & Jerlhag, E. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents. Psychoneuroendocrinology 103, 284\u2013295 (2019).","journal-title":"Psychoneuroendocrinology"},{"key":"17927_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.pbb.2017.07.014","volume":"160","author":"M Thomsen","year":"2017","unstructured":"Thomsen, M. et al. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice. Pharmacol. Biochem. Behav. 160, 14\u201320 (2017).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"17927_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00213-018-5089-z","volume":"236","author":"M Thomsen","year":"2019","unstructured":"Thomsen, M. et al. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring Vervet monkeys. Psychopharmacology 236, 603\u2013611 (2019).","journal-title":"Psychopharmacology"},{"key":"17927_CR15","doi-asserted-by":"crossref","unstructured":"Chuong, V. et al. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight 8, (2023).","DOI":"10.1172\/jci.insight.170671"},{"key":"17927_CR16","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","volume":"15","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nat. Commun. 15, 4548 (2024).","journal-title":"Nat. Commun."},{"key":"17927_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcpt.13776","volume":"131","author":"IK Wium-Andersen","year":"2022","unstructured":"Wium-Andersen, I. K. et al. Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events. A nationwide register-based cohort and self-controlled case series study. Basic. Clin. Pharmacol. Toxicol. 131, 372\u2013379 (2022).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"17927_CR18","doi-asserted-by":"publisher","first-page":"20998","DOI":"10.1038\/s41598-023-48267-2","volume":"13","author":"F Quddos","year":"2023","unstructured":"Quddos, F. et al. Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity. Sci. Rep. 13, 20998 (2023).","journal-title":"Sci. Rep."},{"key":"17927_CR19","doi-asserted-by":"crossref","unstructured":"Klausen, M. K. et al. Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial. JCI Insight 7, (2022).","DOI":"10.1172\/jci.insight.159863"},{"key":"17927_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/acer.70041","author":"ME Jensen","year":"2025","unstructured":"Jensen, M. E. et al. Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumption. Alcohol Clin. Exp. Res. (Hoboken). https:\/\/doi.org\/10.1111\/acer.70041 (2025).","journal-title":"Alcohol Clin. Exp. Res. (Hoboken)"},{"key":"17927_CR21","doi-asserted-by":"publisher","first-page":"e170419","DOI":"10.1172\/jci.insight.170419","volume":"8","author":"L Probst","year":"2023","unstructured":"Probst, L. et al. Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight. 8, e170419 (2023).","journal-title":"JCI Insight"},{"key":"17927_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","volume":"82","author":"CS Hendershot","year":"2025","unstructured":"Hendershot, C. S. et al. Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial: A randomized clinical trial. JAMA Psychiatry. 82, 395\u2013405 (2025).","journal-title":"JAMA Psychiatry"},{"key":"17927_CR23","doi-asserted-by":"publisher","first-page":"116ra6","DOI":"10.1126\/scitranslmed.3002902","volume":"4","author":"JM Mitchell","year":"2012","unstructured":"Mitchell, J. M. et al. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci. Transl Med. 4, 116ra6 (2012).","journal-title":"Sci. Transl Med."},{"key":"17927_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0022-3565(25)39420-6","volume":"267","author":"F Weiss","year":"1993","unstructured":"Weiss, F., Lorang, M. T., Bloom, F. E. & Koob, G. F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J. Pharmacol. Exp. Ther. 267, 250\u2013258 (1993).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"17927_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/dom.14944","volume":"25","author":"M Jensterle","year":"2023","unstructured":"Jensterle, M. et al. Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity. Diabetes Obes. Metab. 25, 975\u2013984 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/dom.13120","volume":"20","author":"JB Hjerpsted","year":"2018","unstructured":"Hjerpsted, J. B. et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obes. Metab. 20, 610\u2013619 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR27","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/dom.14373","volume":"23","author":"K Dahl","year":"2021","unstructured":"Dahl, K. et al. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes. Metab. 23, 1594\u20131603 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/ijo.2013.162","volume":"38","author":"J van Can","year":"2014","unstructured":"van Can, J. et al. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int. J. Obes. (Lond). 38, 784\u2013793 (2014).","journal-title":"Int. J. Obes. (Lond)"},{"key":"17927_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/dom.13956","volume":"22","author":"KL Jones","year":"2020","unstructured":"Jones, K. L. et al. Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations. Diabetes Obes. Metab. 22, 788\u2013797 (2020).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2337\/dc14-1984","volume":"38","author":"JJ Meier","year":"2015","unstructured":"Meier, J. J. et al. Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: A randomized, open-label trial. Diabetes Care. 38, 1263\u20131273 (2015).","journal-title":"Diabetes Care"},{"key":"17927_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/dom.12247","volume":"16","author":"Y Nagai","year":"2014","unstructured":"Nagai, Y. et al. Differing effects of liraglutide on gastric emptying in Japanese patients with type 2 diabetes. Diabetes Obes. Metab. 16, 573\u2013576 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","volume":"151","author":"H Linnebjerg","year":"2008","unstructured":"Linnebjerg, H. et al. Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul. Pept. 151, 123\u2013129 (2008).","journal-title":"Regul. Pept."},{"key":"17927_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.regpep.2013.04.001","volume":"185","author":"M Lorenz","year":"2013","unstructured":"Lorenz, M. et al. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes\u2013relationship to postprandial glycemia. Regul. Pept. 185, 1\u20138 (2013).","journal-title":"Regul. Pept."},{"key":"17927_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/dom.13935","volume":"22","author":"JJ Meier","year":"2020","unstructured":"Meier, J. J. et al. Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes. Diabetes Obes. Metab. 22, 599\u2013611 (2020).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/dom.13633","volume":"21","author":"KL Jones","year":"2019","unstructured":"Jones, K. L. et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes. Metab. 21, 1158\u20131167 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"17927_CR36","doi-asserted-by":"publisher","first-page":"e13313","DOI":"10.1111\/nmo.13313","volume":"30","author":"V Chedid","year":"2018","unstructured":"Chedid, V. et al. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study. Neurogastroenterol Motil. 30, e13313 (2018).","journal-title":"Neurogastroenterol Motil."},{"key":"17927_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2012.02.016","volume":"97","author":"M Horowitz","year":"2012","unstructured":"Horowitz, M. et al. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res. Clin. Pract. 97, 258\u2013266 (2012).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"17927_CR38","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1185\/03007990802418851","volume":"24","author":"RA DeFronzo","year":"2008","unstructured":"DeFronzo, R. A. et al. Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study. Curr. Med. Res. Opin. 24, 2943\u20132952 (2008).","journal-title":"Curr. Med. Res. Opin."},{"key":"17927_CR39","doi-asserted-by":"publisher","first-page":"e002208","DOI":"10.1136\/bmjdrc-2021-002208","volume":"9","author":"M Hompesch","year":"2021","unstructured":"Hompesch, M. et al. Effects of Efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study. BMJ Open. Diabetes Res. Care. 9, e002208 (2021).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"17927_CR40","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2337\/dc20-0190","volume":"43","author":"CK Rayner","year":"2020","unstructured":"Rayner, C. K. et al. Effects of sustained treatment with lixisenatide on gastric emptying and postprandial glucose metabolism in type 2 diabetes: A randomized controlled trial. Diabetes Care. 43, 1813\u20131821 (2020).","journal-title":"Diabetes Care"},{"key":"17927_CR41","doi-asserted-by":"crossref","unstructured":"Jalleh, R. et al. Acute effects of lixisenatide on energy intake in healthy subjects and patients with type 2 diabetes: Relationship to gastric emptying and intragastric distribution. Nutrients 12, 1962  (2020).","DOI":"10.3390\/nu12071962"},{"key":"17927_CR42","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S2468-1253(24)00188-2","volume":"9","author":"RJ Jalleh","year":"2024","unstructured":"Jalleh, R. J. et al. Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. Lancet Gastroenterol. Hepatol. 9, 957\u2013964 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"17927_CR43","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1365-2982.2007.01079.x","volume":"20","author":"PM Hellstr\u00f6m","year":"2008","unstructured":"Hellstr\u00f6m, P. M. et al. GLP-1 suppresses Gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil. 20, 649\u2013659 (2008).","journal-title":"Neurogastroenterol Motil."},{"key":"17927_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neubiorev.2015.06.012","volume":"56","author":"F Allain","year":"2015","unstructured":"Allain, F., Minogianis, E. A., Roberts, D. C. S. & Samaha, A. N. How fast and how often: the pharmacokinetics of drug use are decisive in addiction. Neurosci. Biobehav Rev. 56, 166\u2013179 (2015).","journal-title":"Neurosci. Biobehav Rev."},{"key":"17927_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0376-8716(93)80006-Z","volume":"32","author":"AJ Budney","year":"1993","unstructured":"Budney, A. J., Higgins, S. T., Bickel, W. & Kent, L. Relationship between intravenous use and achieving initial cocaine abstinence. Drug Alcohol Depend. 32, 133\u2013142 (1993).","journal-title":"Drug Alcohol Depend."},{"key":"17927_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0376-8716(98)00103-3","volume":"53","author":"MJ Carpenter","year":"1998","unstructured":"Carpenter, M. J., Chutuape, M. A. & Stitzer, M. L. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend. 53, 11\u201315 (1998).","journal-title":"Drug Alcohol Depend."},{"key":"17927_CR47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0306-4603(99)00036-2","volume":"24","author":"CP Ferri","year":"1999","unstructured":"Ferri, C. P. & Gossop, M. Route of cocaine administration: patterns of use and problems among a Brazilian sample. Addict. Behav. 24, 815\u2013821 (1999).","journal-title":"Addict. Behav."},{"key":"17927_CR48","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1360-0443.1992.tb02660.x","volume":"87","author":"M Gossop","year":"1992","unstructured":"Gossop, M., Griffiths, P., Powis, B. & Strang, J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br. J. Addict. 87, 1527\u20131536 (1992).","journal-title":"Br. J. Addict."},{"key":"17927_CR49","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/jama.1996.03540190052029","volume":"276","author":"DK Hatsukami","year":"1996","unstructured":"Hatsukami, D. K. & Fischman, M. W. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 276, 1580\u20131588 (1996).","journal-title":"JAMA"},{"key":"17927_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10550490701389864","volume":"16","author":"RA Rawson","year":"2007","unstructured":"Rawson, R. A., Gonzales, R., Marinelli-Casey, P. & Ang, A. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Am. J. Addict. 16, 291\u2013299 (2007).","journal-title":"Am. J. Addict."},{"key":"17927_CR51","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.forsciint.2014.03.019","volume":"239","author":"P Kriikku","year":"2014","unstructured":"Kriikku, P. et al. Comparison of breath-alcohol screening test results with venous blood alcohol concentration in suspected drunken drivers. Forensic Sci. Int. 239, 57\u201361 (2014).","journal-title":"Forensic Sci. Int."},{"key":"17927_CR52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/jat\/bkab086","volume":"46","author":"L Skaggs","year":"2022","unstructured":"Skaggs, L., Heizler, A., Kalscheur, D., Miles, A. & Barkholtz, H. M. Comparison of breath- and blood-alcohol concentrations in a controlled drinking study. J. Anal. Toxicol. 46, 683\u2013688 (2022).","journal-title":"J. Anal. Toxicol."},{"key":"17927_CR53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","volume":"632","author":"KP Huang","year":"2024","unstructured":"Huang, K. P. et al. Dissociable hindbrain GLP1R circuits for satiety and aversion. Nature 632, 585\u2013593 (2024).","journal-title":"Nature"},{"key":"17927_CR54","doi-asserted-by":"publisher","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","volume":"310","author":"SE Kanoski","year":"2016","unstructured":"Kanoski, S. E., Hayes, M. R. & Skibicka, K. P. GLP-1 and weight loss: unraveling the diverse neural circuitry. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R885\u2013R895 (2016).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"17927_CR55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1037\/pha0000620","volume":"31","author":"ML Allingbjerg","year":"2023","unstructured":"Allingbjerg, M. L., Hansen, S. N., Secher, A. & Thomsen, M. Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice. Exp. Clin. Psychopharmacol. 31, 612\u2013620 (2023).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"17927_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41386-020-0786-9","volume":"46","author":"L Canchy","year":"2021","unstructured":"Canchy, L., Girardeau, P., Durand, A., Vouillac-Mendoza, C. & Ahmed, S. H. Pharmacokinetics Trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction. Neuropsychopharmacology 46, 288\u2013296 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"17927_CR57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41386-024-01803-8","volume":"49","author":"P Manza","year":"2024","unstructured":"Manza, P. et al. Brain connectivity changes to fast versus slow dopamine increases. Neuropsychopharmacology 49, 924\u2013932 (2024).","journal-title":"Neuropsychopharmacology"},{"key":"17927_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0376-8716(00)00204-0","volume":"63","author":"G Barrio","year":"2001","unstructured":"Barrio, G. et al. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend. 63, 169\u2013177 (2001).","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl 1","key":"17927_CR59","first-page":"11S","volume":"11","author":"DJ Greenblatt","year":"1981","unstructured":"Greenblatt, D. J., Shader, R. I., Divoll, M. & Harmatz, J. S. Benzodiazepines: a summary of Pharmacokinetic properties. Br. J. Clin. Pharmacol. 11 (Suppl 1), 11S\u201316S (1981).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"17927_CR60","first-page":"30","volume":"99","author":"RT Jones","year":"1990","unstructured":"Jones, R. T. The Pharmacology of cocaine smoking in humans. NIDA Res. Monogr. 99, 30\u201341 (1990).","journal-title":"NIDA Res. Monogr."},{"key":"17927_CR61","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","volume":"70","author":"SR Klein","year":"2023","unstructured":"Klein, S. R., Hobai, I. A. & Semaglutide Delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Can. J. Anaesth. 70, 1394\u20131396 (2023).","journal-title":"Can. J. Anaesth."},{"key":"17927_CR62","first-page":"e42153","volume":"15","author":"E Fujino","year":"2023","unstructured":"Fujino, E., Cobb, K. W., Schoenherr, J., Gouker, L. & Lund, E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus 15, e42153 (2023).","journal-title":"Cureus"},{"key":"17927_CR63","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","volume":"70","author":"MA Gulak","year":"2023","unstructured":"Gulak, M. A. & Murphy, P. Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report. Can. J. Anaesth. 70, 1397\u20131400 (2023).","journal-title":"Can. J. Anaesth."},{"key":"17927_CR64","doi-asserted-by":"publisher","first-page":"eRC0628","DOI":"10.31744\/einstein_journal\/2023RC0628","volume":"21","author":"VNF Queiroz","year":"2023","unstructured":"Queiroz, V. N. F. et al. Risk of pulmonary aspiration during semaglutide use and anesthesia in a fasting patient: a case report with tomographic evidence. Einstein (Sao Paulo). 21, eRC0628 (2023).","journal-title":"Einstein (Sao Paulo)"},{"key":"17927_CR65","first-page":"e59319","volume":"16","author":"D Hejdak","year":"2024","unstructured":"Hejdak, D., Razzak, A. N., Sun, L., Rahman, M. & Jha, P. Interaction of semaglutide and Ziprasidone in a patient with schizophrenia: A case report. Cureus 16, e59319 (2024).","journal-title":"Cureus"},{"key":"17927_CR66","doi-asserted-by":"publisher","first-page":"e12278","DOI":"10.1002\/anr3.12278","volume":"12","author":"SA Avraham","year":"2024","unstructured":"Avraham, S. A., Hossein, J., Somri, F., Hawash, N. & Hochman, O. Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss. Anaesth. Rep. 12, e12278 (2024).","journal-title":"Anaesth. Rep."},{"key":"17927_CR67","first-page":"e11735","volume":"12","author":"S Almustanyir","year":"2020","unstructured":"Almustanyir, S., Alhabeeb, H. & AlHusseini, N. Al thow, M. Gastroparesis with the initiation of liraglutide: A case report. Cureus 12, e11735 (2020).","journal-title":"Cureus"},{"key":"17927_CR68","first-page":"e26916","volume":"14","author":"Y Ishihara","year":"2022","unstructured":"Ishihara, Y., Nishiguchi, S., Branch, J. & Tanaka, E. Suspected gastroparesis with concurrent gastroesophageal reflux disease induced by low-dose liraglutide. Cureus 14, e26916 (2022).","journal-title":"Cureus"},{"key":"17927_CR69","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1464-5491.2009.02789.x","volume":"26","author":"AN Paisley","year":"2009","unstructured":"Paisley, A. N., Savage, M. W. & Wiles, P. G. Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus. Diabet. Med. 26, 935\u2013938 (2009).","journal-title":"Diabet. Med."},{"key":"17927_CR70","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s11695-018-3249-1","volume":"28","author":"R Modi","year":"2018","unstructured":"Modi, R., Rye, P., Cawsey, S., Birch, D. W. & Sharma, A. M. Liraglutide effects on upper Gastrointestinal investigations: implications prior to bariatric surgery. Obes. Surg. 28, 2113\u20132116 (2018).","journal-title":"Obes. Surg."},{"key":"17927_CR71","first-page":"e01762","volume":"18","author":"JA Hodgson","year":"2024","unstructured":"Hodgson, J. A., Rivera-Rodriguez, H., Wu, P., Udani, J. & Weiss, J. Point-of-care ultrasound aids in the management of patient taking semaglutide before surgery: A case report. Pract. 18, e01762 (2024).","journal-title":"Pract."},{"key":"17927_CR72","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ALN.0000000000004752","volume":"140","author":"MM Weber","year":"2024","unstructured":"Weber, M. M. Trust the gold standard: all glucagon-like peptide-1 receptor agonists can delay gastric emptying. Anesthesiology 140, 178\u2013180 (2024).","journal-title":"Anesthesiology"},{"key":"17927_CR73","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1111\/dom.14473","volume":"23","author":"M Horowitz","year":"2021","unstructured":"Horowitz, M. et al. Response to Dahl et al.: oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes. Metabolism. 23, 2411\u20132413 (2021).","journal-title":"Diabetes Obes. Metabolism"},{"key":"17927_CR74","first-page":"405","volume":"24","author":"E Baraona","year":"2000","unstructured":"Baraona, E. Site and quantitative importance of alcohol first-pass metabolism. Alcohol Clin. Exp. Res. 24, 405\u2013406 (2000).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"17927_CR75","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/j.1530-0277.2010.01290.x","volume":"34","author":"D Falk","year":"2010","unstructured":"Falk, D. et al. Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials: efficacy endpoint for alcohol trials. Alcohol Clin. Exp. Res. 34, 2022\u20132034 (2010).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"17927_CR76","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1176\/appi.ajp.21090963","volume":"179","author":"BT Hagman","year":"2022","unstructured":"Hagman, B. T., Falk, D., Litten, R. & Koob, G. F. Defining recovery from alcohol use disorder: development of an NIAAA research definition. Am. J. Psychiatry. 179, 807\u2013813 (2022).","journal-title":"Am. J. Psychiatry"},{"key":"17927_CR77","unstructured":"National Institute on Drug Abuse. Advancing reduction of drug use as an endpoint in addiction treatment trials. National Institute on Drug Abuse (2025). https:\/\/nida.nih.gov\/about-nida\/noras-blog\/2025\/03\/advancing-reduction-drug-use-endpoint-in-addiction-treatment-trials"},{"key":"17927_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","volume":"24","author":"A Flint","year":"2000","unstructured":"Flint, A., Raben, A., Blundell, J. E. & Astrup, A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord. 24, 38\u201348 (2000).","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"17927_CR79","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15288\/jsa.1995.56.423","volume":"56","author":"MJ Bohn","year":"1995","unstructured":"Bohn, M. J., Babor, T. F. & Kranzler, H. R. The alcohol use disorders identification test (AUDIT): validation of a screening instrument for use in medical settings. J. Stud. Alcohol. 56, 423\u2013432 (1995).","journal-title":"J. Stud. Alcohol"},{"key":"17927_CR80","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn, M. J., Krahn, D. D. & Staehler, B. A. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin. Exp. Res. 19, 600\u2013606 (1995).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"17927_CR81","first-page":"117822182311575","volume":"17","author":"C Marini","year":"2023","unstructured":"Marini, C. et al. A systematic approach to standardizing drinking outcomes from timeline followback data. Subst. Abuse. 17, 11782218231157558 (2023).","journal-title":"Subst. Abuse"},{"key":"17927_CR82","unstructured":"People Expand Collapse. Biphasic Alcohol Effects Scale (BAES). Addiction Research Center https:\/\/arc.psych.wisc.edu\/self-report\/biphasic-alcohol-effects-scale-baes\/."},{"key":"17927_CR83","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1530-0277.2006.00155.x","volume":"30","author":"J Brick","year":"2006","unstructured":"Brick, J. Standardization of alcohol calculations in research. Alcohol Clin. Exp. Res. 30, 1276\u20131287 (2006).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"17927_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., M\u00e4chler, M., Bolker, B. & Walker, S. Fitting linear Mixed-Effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"17927_CR85","doi-asserted-by":"crossref","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. LmerTest package: tests in linear mixed effects models. J Stat. Softw 82, (2017).","DOI":"10.18637\/jss.v082.i13"},{"key":"17927_CR86","unstructured":"Companion to Applied Regression [R package car version 3.1-3]. (2024)."},{"key":"17927_CR87","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.21105\/joss.02815","volume":"5","author":"M Ben-Shachar","year":"2020","unstructured":"Ben-Shachar, M., L\u00fcdecke, D., Makowski, D. & Effectsize Estimation of effect size indices and standardized parameters. J. Open. Source Softw. 5, 2815 (2020).","journal-title":"J. Open. Source Softw."},{"key":"17927_CR88","unstructured":"Lenth, R. V. Estimated Marginal Means, aka Least-Squares Means [R package emmeans version 1.11.0]. (2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17927-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17927-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17927-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:05:33Z","timestamp":1760519133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17927-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17927-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32385"}}